Not long after, another team confirmed that the MEG3/miR-361-5p/forkhead box M1 (FoxM1) signaling axis may be a diagnostic biomarker or therapeutic target for osteosarcoma (Shen et al., 2019). This evidence concerns the gene FOXM1 and osteosarcoma.